Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis

Pediatric Pulmonology

Volumn 28, Issue 5, 1999, Pages 380-382

  Nasr, Samya Z ^a   Hurwitz, Martin E ^a   Brown, Randall W ^a   Elghoroury, Mahmoud ^b   Rosen, David ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HURLEY MEDICAL CENTER   (United States)

Author keywords

Anorexia; Cystic fibrosis; Megestrol acetate

Indexed keywords

MEGESTROL ACETATE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BODY WEIGHT; CASE REPORT; CHILD; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG DISEASE; MALE; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0032716920     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199911)28:5<380::AID-PPUL11>3.0.CO;2-A     Document Type: Article

References (16)

1. Cystic Fibrosis Foundation, Patient Registry 1996 Annual Data Report, Bethesda, Maryland, August 1997.
2. Durie PR, Pencharz PB. A rational approach to the nutritional care of patients with cystic fibrosis. J Roy Soc Med 1989;82(suppl 17):11-20.
3. Levy L, Durie P, Pencharz P, Corey M. Prognostic factors associated with patient survival during nutritional rehabilitation in malnourished children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986;5:97-102.
4. Alexieva-Figusch J, vanGilse HA, Hop WCJ. Progestin therapy in advanced breast cancer. Megestrol acetate - an evaluation of 160 treated cases. Cancer 1980;46:2369-2372.
5. Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients. Anticanc Res 1997; 17:657-662.
6. McCarthy H, Crowder R. Dryden S, Williams G. Megesterol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations. Eur J Pharmacol 1994;265(1-2):99-102.
7. Tierney AR, Cuff P. Kotler DP. The effect of megestrol acetate-(Megace) on appetite, nutritional repletion and quality of life in AIDS cachexia. [Abstract MB2263]. Presented at the Seventh International Conference on AIDS, Florence, Italy, June 16-21, 1991.
8. von Roenn JH, Roth EL, Craig R. HIV-related cachexia: potential mechanisms and treatment. Oncology 1992;49(suppl 2):50-54
9. Tchekmedyian NS, Hickman M, Heber D. Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome. Semin Oncol 1991; 18(Suppl 2):35-42.
10. Feliu J, Gonzalez-Baron M, Berrocal A. Usefulness of megestrol acetate in cancer cachexia and anorexia: a placebo-controlled study. Am J Clin Oncol 1992;15:436-40.
11. Brady MT, Koranyi KI, Hunkler JA. Megestrol acetate for treatment of anorexia associated with human immunodeficiency virus infection in children. Pediatr Infect Dis J 1994;13:754-6.
12. Brasfield D, Hicks G, Seng-Jaw S, Tiller RE. The roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979;63:24-29.
13. Shwachman H, Kulczycki LL. Long-term study of 105 patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
14. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-188.
15. Konstan MW, Berger M. Infection and inflammation of the lung in cystic fibrosis. In: Davis PB, ed. Cystic fibrosis. Vol.64 of Lung biology in health and disease. New York: Marcel Dekker 1993: 219-276.
16. Subramanian S, Goher H, Kanji A, Sweeney H. Clinical adrenal insufficiency in patients receiving megestrol therapy. Arch Intern Med 1997;157:1008-1011.